# Novartis Pharmaceuticals Corp., Suffern, NY – FDA Inspections

Source: https://www.keypedia.com/companies/novartis-pharmaceuticals-corp/f61e16e5-6ca9-432d-a015-9e5a541a0674

> Inspection records and compliance data for Novartis Pharmaceuticals Corp. in Suffern, New York. 9 FDA inspections on record, last inspected July 14, 2015.

---

## Details

- Name: Novartis Pharmaceuticals Corp.
- FEI Number: 2416082
- Address Line 1: 25 Old Mill Rd
- City: Suffern
- State: New York
- Zip Code: 10901
- Country Name: United States
- Address: 25 Old Mill Rd, Suffern, New York 10901, United States
- Country: United States

## Related Documents

- FDA Inspection 936188 - Novartis Pharmaceuticals Corp. - 2015-07-14 — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2015
- FDA Inspection 866692 - Novartis Pharmaceuticals Corp. - 2014-02-11 — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2014
- [FDA Inspection 811624 - Novartis Pharmaceuticals Corp. - 2012-12-19](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/229bd035-f48f-4dc4-b65a-35c52cc06b95) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2012
- [FDA Inspection 764997 - Novartis Pharmaceuticals Corp. - 2012-01-31](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/a6ff6688-fb83-4e60-81c0-b8321b957f80) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2012
- [FDA Inspection 704290 - Novartis Pharmaceuticals Corp. - 2010-12-21](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/2b81d150-e371-43c3-8aad-2a7cc5e026dc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2010
- [FDA Inspection 680379 - Novartis Pharmaceuticals Corp. - 2010-09-16](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/7ab36698-ba47-4012-98ac-cac9115a1b78) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2010
- [FDA Inspection 643624 - Novartis Pharmaceuticals Corp. - 2010-02-09](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/46c998a4-3857-4aba-94a3-4e0c4903968a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 9, 2010
- [FDA Inspection 572781 - Novartis Pharmaceuticals Corp. - 2009-03-31](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/1803445d-1bb6-4ddb-8d92-cac99a33ef16) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2009
- FDA Inspection 547958 - Novartis Pharmaceuticals Corp. - 2008-11-20 — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2008

## Related Companies

- [New York Medical College IRB](https://www.keypedia.com/companies/new-york-medical-college-irb/97f5e01b-5680-4fe4-9808-c64134d1e7c3)
- [Dr. William Tap](https://www.keypedia.com/companies/dr-william-tap/9e4243dd-bcfd-469f-a333-3501ced017f6)
- [Meghna Trivedi, M.D.](https://www.keypedia.com/companies/meghna-trivedi-md/369ad7e7-55a8-417d-b66c-66daec2b2700)
- [Elaine Shum, M.D.](https://www.keypedia.com/companies/elaine-shum-md/52cac6fb-e59f-44bf-9ac4-2abef7ded1c4)
- [Sandra Comer](https://www.keypedia.com/companies/sandra-comer/a254c2b8-9f17-4c10-b01a-b2171130a53c)
- [Glenn S. Hamroff , M.D.](https://www.keypedia.com/companies/glenn-s-hamroff-md/5ce25507-a678-4f0f-8e6d-c39c0735ace7)
- [Dana E. Rathkopf , M.D.](https://www.keypedia.com/companies/dana-e-rathkopf-md/22dd2742-a958-4ce4-8248-afd5e1df6263)
- [Research Foundation for Mental Health IRB](https://www.keypedia.com/companies/research-foundation-for-mental-health-irb/031e7cf5-162c-4c4b-8362-dc504d26138e)
- [Matthew D. Galsky](https://www.keypedia.com/companies/matthew-d-galsky/8f8337ab-5a1a-4340-860f-3d1133b94d9d)
- [Lindsey Roeker, M.D.](https://www.keypedia.com/companies/lindsey-roeker-md/cb397bdb-081c-45c1-81c5-c9376e63d2d5)